112 related articles for article (PubMed ID: 30690330)
1. Trends of incidence and survival of patients with chronic myelomonocytic leukemia between 1999 and 2014: A comparison between Swiss and American population-based cancer registries.
Benzarti S; Daskalakis M; Feller A; Bacher VU; Schnegg-Kaufmann A; Rüfer A; Holbro A; Schmidt A; Benz R; Solenthaler M; Stussi G; Arndt V; Bonadies N;
Cancer Epidemiol; 2019 Apr; 59():51-57. PubMed ID: 30690330
[TBL] [Abstract][Full Text] [Related]
2. Hypomethylating agent therapy use and survival in older patients with chronic myelomonocytic leukemia in the United States: A large population-based study.
Zeidan AM; Hu X; Long JB; Wang R; Ma X; Podoltsev NA; Huntington SF; Gore SD; Davidoff AJ
Cancer; 2017 Oct; 123(19):3754-3762. PubMed ID: 28621841
[TBL] [Abstract][Full Text] [Related]
3. Incidence and survival outcomes of chronic myelomonocytic leukemia in the United States.
Guru Murthy GS; Dhakal I; Mehta P
Leuk Lymphoma; 2017 Jul; 58(7):1648-1654. PubMed ID: 27881041
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs.
Rollison DE; Howlader N; Smith MT; Strom SS; Merritt WD; Ries LA; Edwards BK; List AF
Blood; 2008 Jul; 112(1):45-52. PubMed ID: 18443215
[TBL] [Abstract][Full Text] [Related]
5. Incidence and survival of chronic myelomonocytic leukemia in Girona (Spain): a population-based study, 1993-2007.
Osca-Gelis G; Puig-Vives M; Saez M; Gallardo D; Solé F; Marcos-Gragera R
Leuk Res; 2012 Oct; 36(10):1262-6. PubMed ID: 22784713
[TBL] [Abstract][Full Text] [Related]
6. Natural history of chronic myelomonocytic leukemia treated with hypomethylating agents.
Alfonso A; Montalban-Bravo G; Takahashi K; Jabbour EJ; Kadia T; Ravandi F; Cortes J; Estrov Z; Borthakur G; Pemmaraju N; Konopleva M; Bueso-Ramos C; Pierce S; Kantarjian H; Garcia-Manero G
Am J Hematol; 2017 Jul; 92(7):599-606. PubMed ID: 28370097
[TBL] [Abstract][Full Text] [Related]
7. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
Milano AF
J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
[TBL] [Abstract][Full Text] [Related]
8. Temporal trend in survival for chronic myelomonocytic leukemia in the US: a population-based study.
Lesegretain A; Brunner A; Benzohra A; Fathi AT
Leuk Lymphoma; 2023 Dec; 64(13):2156-2164. PubMed ID: 37715313
[TBL] [Abstract][Full Text] [Related]
9. Incidence patterns of colorectal cancers in four countries of the Middle East Cancer Consortium (Cyprus, Jordan, Israel, and İzmir, Turkey) compared with those in the United States Surveillance, Epidemiology, and End Results Program.
Eser S; Chang J; Charalambous H; Silverman B; Demetriou A; Yakut C; Nimri O; Pavlou P; Özgür S; Ziogas A; Stevens L; Ward K; Anton Culver H
Turk J Gastroenterol; 2018 Jan; 29(1):36-44. PubMed ID: 29391306
[TBL] [Abstract][Full Text] [Related]
10. Second malignancies in survivors of chronic myelomonocytic leukemia: a U.S. population-based study.
El-Fattah MA
Leuk Lymphoma; 2017 Sep; 58(9):1-7. PubMed ID: 28092999
[No Abstract] [Full Text] [Related]
11. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
12. Differences in childhood leukemia incidence and survival between Southern Thailand and the United States: a population-based analysis.
Demanelis K; Sriplung H; Meza R; Wiangnon S; Rozek LS; Scheurer ME; Lupo PJ
Pediatr Blood Cancer; 2015 Oct; 62(10):1790-8. PubMed ID: 25962869
[TBL] [Abstract][Full Text] [Related]
13. Malignant central nervous system tumors among adolescents and young adults (15-39 years old) in 14 Southern-Eastern European registries and the US Surveillance, Epidemiology, and End Results program: Mortality and survival patterns.
Georgakis MK; Papathoma P; Ryzhov A; Zivkovic-Perisic S; Eser S; Taraszkiewicz Ł; Sekerija M; Žagar T; Antunes L; Zborovskaya A; Bastos J; Florea M; Coza D; Demetriou A; Agius D; Strahinja RM; Themistocleous M; Tolia M; Tzanis S; Alexiou GA; Papanikolaou PG; Nomikos P; Kantzanou M; Dessypris N; Pourtsidis A; Petridou ET
Cancer; 2017 Nov; 123(22):4458-4471. PubMed ID: 28708937
[TBL] [Abstract][Full Text] [Related]
14. Comparison of prostate cancer survival in Germany and the USA: can differences be attributed to differences in stage distributions?
Winter A; Sirri E; Jansen L; Wawroschek F; Kieschke J; Castro FA; Krilaviciute A; Holleczek B; Emrich K; Waldmann A; Brenner H;
BJU Int; 2017 Apr; 119(4):550-559. PubMed ID: 27208546
[TBL] [Abstract][Full Text] [Related]
15. Trends in breast cancer by race and ethnicity: update 2006.
Smigal C; Jemal A; Ward E; Cokkinides V; Smith R; Howe HL; Thun M
CA Cancer J Clin; 2006; 56(3):168-83. PubMed ID: 16737949
[TBL] [Abstract][Full Text] [Related]
16. Incidence and time trends of childhood lymphomas: findings from 14 Southern and Eastern European cancer registries and the Surveillance, Epidemiology and End Results, USA.
Georgakis MK; Karalexi MA; Agius D; Antunes L; Bastos J; Coza D; Demetriou A; Dimitrova N; Eser S; Florea M; Ryzhov A; Sekerija M; Žagar T; Zborovskaya A; Zivkovic S; Bouka E; Kanavidis P; Dana H; Hatzipantelis E; Kourti M; Moschovi M; Polychronopoulou S; Stiakaki E; Kantzanou Μ; Pourtsidis A; Petridou ET
Cancer Causes Control; 2016 Nov; 27(11):1381-1394. PubMed ID: 27757777
[TBL] [Abstract][Full Text] [Related]
17. Improvement of relative survival in elderly patients with acute myeloid leukaemia emerging from population-based cancer registries in Switzerland between 2001 and 2013.
Schnegg-Kaufmann A; Feller A; Baldomero H; Rovo A; Manz MG; Gregor M; Efthymiou A; Bargetzi M; Hess U; Spertini O; Chalandon Y; Passweg JR; Stussi G; Arndt V; Bonadies N;
Cancer Epidemiol; 2018 Feb; 52():55-62. PubMed ID: 29223104
[TBL] [Abstract][Full Text] [Related]
18. Cancers of the upper aerodigestive tract in Ontario, Canada, and the United States.
Skarsgard DP; Groome PA; Mackillop WJ; Zhou S; Rothwell D; Dixon PF; O'Sullivan B; Hall SF; Holowaty EJ
Cancer; 2000 Apr; 88(7):1728-38. PubMed ID: 10738233
[TBL] [Abstract][Full Text] [Related]
19. Recent improvement in completeness of incidence data on acute myeloid leukemia in US cancer registries.
Polednak AP
J Registry Manag; 2014; 41(2):77-84. PubMed ID: 25153013
[TBL] [Abstract][Full Text] [Related]
20. Trends in pancreatic cancer incidence in nine SEER Cancer Registries, 1973-2002.
Zhang J; Dhakal I; Yan H; Phillips M; Kesteloot H;
Ann Oncol; 2007 Jul; 18(7):1268-79. PubMed ID: 17488731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
